U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. ESPEROCT
  1. Vaccines, Blood & Biologics

ESPEROCT

STN: BL 125671/197
Proper Name: Antihemophilic Factor (Recombinant), GlycoPEGylated-exei
Tradename: Esperoct
Manufacturer: Novo Nordisk, Inc.
Indication: 

  • Adults and children with hemophilia A for control and prevention of bleeding, perioperative management, and routine prophylaxis to reduce the frequency of bleeding episodes.

Product Information

Supporting Documents

Back to Top